NZ250879A - Benzimidazoles and purines; medicaments - Google Patents
Benzimidazoles and purines; medicamentsInfo
- Publication number
- NZ250879A NZ250879A NZ250879A NZ25087994A NZ250879A NZ 250879 A NZ250879 A NZ 250879A NZ 250879 A NZ250879 A NZ 250879A NZ 25087994 A NZ25087994 A NZ 25087994A NZ 250879 A NZ250879 A NZ 250879A
- Authority
- NZ
- New Zealand
- Prior art keywords
- benzimidazoles
- purines
- medicaments
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE4304650A DE4304650A1 (en) | 1993-02-16 | 1993-02-16 | Condensed 5-membered heterocycles, processes for their preparation and pharmaceutical compositions containing them |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ250879A true NZ250879A (en) | 1995-09-26 |
Family
ID=6480585
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ250879A NZ250879A (en) | 1993-02-16 | 1994-02-15 | Benzimidazoles and purines; medicaments |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP0611660A3 (en) |
| JP (1) | JPH072839A (en) |
| AU (1) | AU5513094A (en) |
| CA (1) | CA2115737A1 (en) |
| DE (1) | DE4304650A1 (en) |
| FI (1) | FI940697A (en) |
| IL (1) | IL108648A0 (en) |
| NO (1) | NO940524D0 (en) |
| NZ (1) | NZ250879A (en) |
| ZA (1) | ZA941021B (en) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2751647B1 (en) * | 1996-07-25 | 1998-09-11 | Synthelabo | BENZIMIDAZOLE DERIVATIVES, THEIR PREPARATIONS AND THEIR THERAPEUTIC APPLICATIONS |
| CA2306870A1 (en) | 1997-10-20 | 1999-04-29 | David Michael Goldstein | Bicyclic kinase inhibitors |
| KR100849839B1 (en) | 2001-02-23 | 2008-08-01 | 머크 앤드 캄파니 인코포레이티드 | N-Substituted nonaryl-heterocyclic NMDA/NR2B antagonists and a pharmaceutical composition comprising the same |
| YU37904A (en) | 2001-11-09 | 2006-08-17 | Boehringer Ingelheim Pharmaceuticals Inc. | Benzimidazoles useful as protein kinase inhibitors |
| JP2005536533A (en) | 2002-08-08 | 2005-12-02 | ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド | Substituted benzimidazole compounds |
| CA2510455C (en) | 2002-12-19 | 2013-03-12 | The Scripps Research Institute | Compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| US7741341B2 (en) | 2003-05-19 | 2010-06-22 | Sanofi-Aventis Deutschland Gmbh | Benzimidazole-derivatives as factor Xa inhibitors |
| EP1479676A1 (en) * | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | Benzimidazole-derivatives as factor xa inhibitors |
| AU2004261667A1 (en) | 2003-08-01 | 2005-02-10 | Genelabs Technologies, Inc. | Bicyclic imidazol derivatives against Flaviviridae |
| EP2314584A1 (en) | 2004-05-20 | 2011-04-27 | Foldrx Pharmaceuticals, Inc. | 2-(heteroaryl)-benzoxazole compounds and derivatives, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| CA2709772A1 (en) * | 2007-12-21 | 2009-07-09 | Endacea, Inc. | A1 adenosine receptor antagonists |
| WO2013038351A1 (en) | 2011-09-16 | 2013-03-21 | Pfizer Inc. | Solid forms of a transthyretin dissociation inhibitor |
| US9637471B2 (en) | 2013-02-14 | 2017-05-02 | Technische Universitat Munchen | Hydroxyindalpine derivatives and their medical use |
| WO2014151630A2 (en) | 2013-03-15 | 2014-09-25 | Irm Llc | Compounds and compositions for the treatment of parasitic diseases |
| US9186361B2 (en) | 2013-03-15 | 2015-11-17 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
| US9296754B2 (en) | 2013-03-15 | 2016-03-29 | Novartis Ag | Compounds and compositions for the treatment of parasitic diseases |
| CA2899646C (en) | 2013-03-15 | 2021-08-31 | Hydra Biosciences, Inc. | Substituted xanthines and methods of use thereof |
| HUE040254T2 (en) | 2013-12-19 | 2019-02-28 | Novartis Ag | [1,2,4]triazolo[1,5-a]pyrimidine derivatives as protozoan proteasome inhibitors for the treatment of parasitic diseases such as leishmaniasis |
| EP3165521B1 (en) * | 2014-07-03 | 2019-01-16 | Shanghai Institute Of Pharmaceutical Industry | Method of preparing dabigatran etexilate intermediate and intermediate compound |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2208367B (en) | 1987-07-09 | 1991-07-03 | Alcatel Business Systems | Franking machine |
| US5084466A (en) * | 1989-01-31 | 1992-01-28 | Hoffmann-La Roche Inc. | Novel carboxamide pyridine compounds which have useful pharmaceutical utility |
| DE4124942A1 (en) * | 1991-07-27 | 1993-01-28 | Thomae Gmbh Dr K | 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENTS CONTAINING SUCH COMPOUNDS |
| DE4129603A1 (en) * | 1991-09-06 | 1993-03-11 | Thomae Gmbh Dr K | CONDENSED 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF, AND MEDICAMENTS CONTAINING THESE COMPOUNDS |
| DE4214245A1 (en) * | 1992-04-30 | 1993-11-04 | Thomae Gmbh Dr K | Labelled fibrinogen receptor antagonists |
| DK0567967T3 (en) * | 1992-04-28 | 1996-11-18 | Thomae Gmbh Dr K | Tritium-labeled fibrinogen receptor antagonists, their use and method for their preparation |
-
1993
- 1993-02-16 DE DE4304650A patent/DE4304650A1/en not_active Withdrawn
-
1994
- 1994-02-14 EP EP9494102222A patent/EP0611660A3/en not_active Withdrawn
- 1994-02-14 JP JP6017568A patent/JPH072839A/en active Pending
- 1994-02-15 ZA ZA941021A patent/ZA941021B/en unknown
- 1994-02-15 FI FI940697A patent/FI940697A/en not_active Application Discontinuation
- 1994-02-15 NO NO940524A patent/NO940524D0/en unknown
- 1994-02-15 IL IL10864894A patent/IL108648A0/en unknown
- 1994-02-15 AU AU55130/94A patent/AU5513094A/en not_active Abandoned
- 1994-02-15 NZ NZ250879A patent/NZ250879A/en unknown
- 1994-02-15 CA CA002115737A patent/CA2115737A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| DE4304650A1 (en) | 1994-08-18 |
| ZA941021B (en) | 1995-08-15 |
| FI940697A (en) | 1994-08-17 |
| JPH072839A (en) | 1995-01-06 |
| IL108648A0 (en) | 1994-05-30 |
| FI940697A0 (en) | 1994-02-15 |
| NO940524L (en) | 1994-08-17 |
| CA2115737A1 (en) | 1994-08-17 |
| EP0611660A3 (en) | 1994-09-14 |
| EP0611660A2 (en) | 1994-08-24 |
| NO940524D0 (en) | 1994-02-15 |
| AU5513094A (en) | 1994-08-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ321576A (en) | 6-imidazol-1-ylmethyl-2-oxo-quinoline derivatives and medicaments | |
| HU9600932D0 (en) | In-alkyl-n-arylpyrimidinamines and derivatives thereof | |
| NZ250879A (en) | Benzimidazoles and purines; medicaments | |
| NZ237790A (en) | Substituted benzimidazoles and medicaments. | |
| GB9202519D0 (en) | Medicaments | |
| NZ231605A (en) | Imidazole derivatives and medicaments | |
| GB9308430D0 (en) | Medicaments | |
| GB9201749D0 (en) | Medicaments | |
| NZ332309A (en) | Alkylamino-benzothiazole and -benzoxazole derivatives and medicaments | |
| GB9216380D0 (en) | Medicaments | |
| GB9315566D0 (en) | Medicaments | |
| GB9313574D0 (en) | Medicaments | |
| GB9314973D0 (en) | Medicaments | |
| AP9300592A0 (en) | Medicaments | |
| NZ248041A (en) | Aminoalkyl- tetrahydrofuran derivatives and medicaments | |
| GB9202522D0 (en) | Medicaments | |
| GB9313649D0 (en) | Medicaments | |
| ZA947352B (en) | Therapeutic benzimidazoles | |
| GB9304021D0 (en) | Medicaments | |
| GB9321194D0 (en) | Medicaments | |
| GB9303188D0 (en) | Medicaments | |
| GB9304010D0 (en) | Medicaments | |
| GB9325335D0 (en) | Medicaments | |
| GB9300568D0 (en) | Benzodioxanylimidazoline and benzodioxanylimidazole derivatives | |
| GB9324403D0 (en) | Benzodioxanylimidazoline and benzodioxanylimidazole derivatives |